Human VIPR1 (Vasoactive intestinal polypeptide receptor 1) ELISA Kit

Este producto es parte de VIPR - Vasoactive Intestinal Peptide Receptor
Human VIPR1 (Vasoactive intestinal polypeptide receptor 1) ELISA Kit
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Human VIPR1 (Vasoactive intestinal polypeptide receptor 1) ELISA Kit
Category
ELISA Kits
Provider
FineTest
Reference
EH1766
Tested Applications
ELISA

Documentos del producto

Instrucciones
Descargar
Data sheet

Especificaciones del producto

Category
ELISA Kits
Reactivity
Human
Detection Method
Colorimetric
Assay Data
4 hours
Assay Type
Sandwich ELISA, Double Antibody
Test Range
0.156-10ng/ml
Sensitivity
0.094ng/ml
Size 1
96T
Tested Applications
ELISA
Sample Type
Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples
Availability
Shipped within 10-14 working days.
Storage
2-8 °C for 12 months
UniProt ID
P32241
Alias
VIPR1,Pituitary adenylate cyclase-activating polypeptide type II receptor,PACAP type II receptor,PACAP-R-2,PACAP-R2,VPAC1
Background
Elisa kits for VIPR1
Status
RUO

Background

VIPR1 is a G protein-coupled receptor activated by vasoactive intestinal peptide (VIP), a neuropeptide involved in regulating smooth muscle relaxation, vasodilation, and neurotransmission. VIPR1 couples to Gs proteins, stimulating adenylate cyclase and increasing cAMP levels, leading to relaxation of smooth muscle cells, dilation of blood vessels, and modulation of gastrointestinal motility. VIPR1 is primarily expressed in the smooth muscle of the gastrointestinal tract, blood vessels, and the central nervous system, where it plays a role in regulating vascular tone, intestinal motility, and neurotransmitter release. VIP has a significant role in regulating inflammation and immune responses, and VIPR1 signaling is involved in modulating immune cell functions. Dysregulation of VIPR1 signaling has been implicated in inflammatory diseases, gastrointestinal disorders, and cardiovascular diseases. Agonists targeting VIPR1 are being investigated for their potential to treat diseases involving smooth muscle contraction and inflammation, such as asthma, irritable bowel syndrome (IBS), and hypertension.

Productos relacionados

abx031167

Vasoactive Intestinal Peptide Receptor (VIPR1) Antibody

This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is i…

Ver producto
abx130405

Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Antibody

Vasoactive Intestinal Peptide Receptor 1 Antibody is a Rabbit Polyclonal against Vasoactive Intestinal Peptide Receptor …

Ver producto
abx153481

Human Vasoactive Intestinal Peptide Receptor 1 (VIPR1) ELISA Kit

Human Vasoactive Intestinal Peptide Receptor 1 (VIPR1) ELISA Kit is an ELISA Kit for the in vitro quantitative measureme…

Ver producto